# Targeted Next Generation Sequencing and Intellectual Disability

> **NCT02889068** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 40 (actual)

## Conditions studied

- Intellectual Disability

## Interventions

- **OTHER:** Blood sample

## Key facts

- **NCT ID:** NCT02889068
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-09-30
- **Final completion:** 2017-01-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02889068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02889068, "Targeted Next Generation Sequencing and Intellectual Disability". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02889068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*